The findings from our work thus suggest that potential application of GPNMB/OA as a therapeutic target for lung cancer should incorporate strategies that will inhibit the mechanism by which GPNMB/OA ECD protein is shed or negate the effects of the GPNMB/OA ECD protein in tumor tissues. Here, GPNMB is linked to neoplasm.